Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Higher fluoride levels may delay puberty in boys.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.